BLNC
Get informed when a big investor buys or sells
+ FollowOvervalued by 100.3% based on the discounted cash flow analysis.
| Market cap | $72.62 Million |
|---|---|
| Enterprise Value | $73.00 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.23 |
| Beta | 1.56 |
| Outstanding Shares | 46,852,319 |
| P/E Ratio | -1.27 |
|---|---|
| PEG | -2.04 |
| Price to Sales | - |
| Price to Book Ratio | -1.55 |
| Enterprise Value to Revenue | 1587.04 |
| Enterprise Value to EBIT | -4.4 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | -0.18 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Balance Labs, Inc. functions as a specialized consultancy, delivering business development and strategic guidance to emerging and growth-phase companies in both domestic U.S. and international markets. The firm assists diverse enterprise...